| Development of a 3D tumor model to validate the therapeutic potential of targeting immunogenic cell death, angiogenic factors, and their regulators in drug-resistant T-ALL; INTR-IG-2023-02-0014 |
New |
2024 |
Dr. Bhavika Rishi |
| Identification of Risk Factors of Gallbladder Cancer and Its Hotspot Mapping in Delhi NCR: A Pilot Study |
New |
2024 |
Ms. Reena Bhardwaj |
| ICMR funded project entitled "A diagnostic randomized controlled trial to study to validate novel DBS based technology for prognosis and screening for leukemia transcripts"; Sanction ref no EM/Dev/NHRP-2023-0001854 (e office-179369) |
New |
2024 |
Dr. Aroonima Misra |
| Identification of novel synergistic inhibitors by studying differences in sensitivity towards pathway regulators and triple inhibitors of I3K/Akt/mTOR axis in T cell ALL |
Current |
2024 |
Dr. Aroonima Misra |
| OMNIVEC-India: Designing and implementing a digital OMNI-channel Community Engagement and Risk Communication intervention for prevention and control of Vector-borne Diseases across India |
Current |
2024 |
Dr. Neeraj Kumar |
| A phase II, multicentre, randomized, two-arm blinded study to assess the efficacy and safety of two LXE408 regimens for treatment of patients with primary visceral leishmaniasis (VL) |
Current |
2024 |
Ms. Reena Bhardwaj |
| Old Drugs New Tricks: Drug Repurposing for Psoriasis Treatment Using In-silico Approach; ICMR ID-2020-4900 |
Completed |
2024 |
Dr. Neeraj Kumar |
| Developing predictive model for the early detection of Intrauterine Growth Restriction (IUGR) in new-borns from polycyclic aromatic hydrocarbons concentration (PAHs) in maternal blood; ICMR- ID-2019-3049 |
Completed |
2024 |
Dr. Neeraj Kumar |
| Integrative analysis of psoriasis transcriptome for identification of potential therapeutic targets; ICMR- ID- 2017-0322 |
Completed |
2024 |
Dr. Neeraj Kumar |
| Immune status against SARS-CoV-2 among COVID-19 vaccinated adults in India: A health facility-based multicentric serial cross-sectional survey |
Completed |
2024 |
Dr. Neeraj Kumar |
| Chronic stool shedding, blood antigenemia, and identification of novel biomarkers as predictors for development of MIS-C in children exposed to SARS CoV2 infection; ICMR-ID 2021-3994 |
Completed |
2024 |
Dr. Bhavika Rishi |